bioRxivImmunology
Autoimmunity increases susceptibility to and mortality from sepsis
I. J. Jensen, S. N. Jensen, P. W. McGonagill, T. S. Griffith, A. K. Mangalam, V. P. Badovinac
Abstract
Our prior publication detailing how sepsis influences subsequent development of EAE presented a conceptual advance in understanding the post-sepsis chronic immunoparalysis state (Jensen et al., 2020). However, the reverse scenario (autoimmunity prior to sepsis) defines a high-risk patient population whose susceptibility to sepsis remains poorly defined. Herein, we present a retrospective analysis of University of Iowa Hospital and Clinics patients demonstrating increased sepsis incidence among MS, relative to non-MS, patients. To interrogate how autoimmune disease influences host susceptibility to sepsis well-established murine models of MS and sepsis, EAE and CLP, respectively, were utilized. EAE, relative to non-EAE, mice were highly susceptible to sepsis-induced mortality with elevated cytokine storms. These results were further recapitulated in LPS and S. pneumoniae sepsis models. This work highlights both the relevance of identifying highly susceptible patient populations and expands the growing body of literature that host immune status at the time of septic insult is a potent mortality determinant.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mucosal-associated invariant T (MAIT) cells mediate protective host responses in sepsis
S. Trivedi, D. Labuz, … D. T. Leung·bioRxiv·Feb 5, 2020
- The Protective Association Of Endogenous Immunoglobulins Against Sepsis Mortality Is Restricted To Patients With Moderate Organ Failure.
I. Martin-Loeches, A. Muriel-Bombin, … GRECIA Group·bioRxiv·Mar 14, 2017
- Role of mast cells in endomicrobial sepsis revisited: Mast cell-deficient mice show normal immunological protection
Thorsten B. Feyerabend, Fabienne Schochter, … Hans-Reimer Rodewald·bioRxiv·Mar 7, 2025
- Azithromycin reduces systemic inflammation and provides survival benefit in murine model of polymicrobial sepsis
- Long-term immune reprogramming of classical monocytes with altered ontogeny mediates enhanced lung injury in sepsis survivors
Scott J. Denstaedt, Breanna McBean, … Rachel L. Zemans·JCI InsightPeer-reviewed·Sep 24, 2026
- Type 1 immunity linked to CMV exposure improves long-term survival in sepsis without shock
Wei Qi, Nuzat Zaman, … Jacques Deguine·bioRxiv·Oct 19, 2026